Real-World Data from Turkey: Is Sofosbuvir/Ledipasvir With or Without Ribavirin Treatment for Chronic Hepatitis C Really Effective?

Background: In this study, we aimed to investigate the efficacy and safety of sofosbuvir-based therapies in the treatment of chronic hepatitis C in real-world clinical practice. Methods: Data from patients with chronic hepatitis C treated with SOF/LDV ± RBV or SOF/RBV in 31 centers across Turkey be...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Neşe Demirtürk, Bilgehan Aygen, İlhami Çelik, Reşit Mıstık, Sıla Akhan, Şener Barut, Onur Ural, Ayşe Batırel, Funda Şimşek, Gülden Ersöz, Dilara İnan, Sami Kınıklı, Nesrin Türker, Hüseyin Bilgin, Yunus Gürbüz, Necla Tülek, Hüseyin Tarakçı, Orhan Yıldız, Emine Türkoğlu, Deniz Kamalak Güzel, Sümeyra Şimşek, Nazan Tuna, Nazlım Aktuğ Demir, Atahan Çağatay, Rıza Aytaç Çetinkaya, Faruk Karakeçili, İsmail Necati Hakyemez, Günay Tuncer Ertem, Bahar Örmen, Pınar Korkmaz, Uluhan Yıldız, Ziya Kuruüzüm, Alper Şener, Selcan Arslan Özel, Sinan Öztürk, Kaya Suer, Mustafa Kemal Çelen, Petek Konya, Ali Asan, Neşe Saltoğlu, Nurhan Doğan
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Turkish Society of Gastroenterology 2021-02-01
סדרה:	The Turkish Journal of Gastroenterology
נושאים:	Chronic hepatitis C sofosbuvir ledipasvir sustained virological response genotype real-world data
גישה מקוונת:	https://turkjgastroenterol.org/index.php/tjg/article/view/3700
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!